- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/14 - Radicals substituted by nitrogen atoms
Patent holdings for IPC class C07D 235/14
Total number of patents in this class: 284
10-year publication summary
|
17
|
18
|
18
|
23
|
19
|
15
|
15
|
16
|
12
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Actelion Pharmaceuticals Ltd | 497 |
6 |
| LG Chem, Ltd. | 17921 |
5 |
| The General Hospital Corporation | 4858 |
5 |
| Abbvie Inc. | 1836 |
5 |
| X4 Pharmaceuticals, Inc. | 93 |
5 |
| VALO Health, Inc. | 193 |
5 |
| Centre National de La Recherche Scientifique | 11016 |
4 |
| Kyoto University | 2898 |
4 |
| Nippon Shinyaku Co., Ltd. | 322 |
4 |
| Cavion, Inc. | 23 |
4 |
| Calico Life Sciences LLC | 107 |
4 |
| The Regents of the University of California | 20720 |
3 |
| Janssen Pharmaceutica N.V. | 3171 |
3 |
| Allergan, Inc. | 2169 |
3 |
| Sumitomo Chemical Company, Limited | 8996 |
3 |
| The Board of Trustees of the University of Illinois | 2750 |
3 |
| Takeda Pharmaceutical Company Limited | 2715 |
3 |
| Antabio SAS | 23 |
3 |
| Concert Pharmaceuticals, Inc. | 244 |
3 |
| Epizyme, Inc. | 359 |
3 |
| Other owners | 206 |